TGIA
GILD icon

Torrey Growth & Income Advisors’s Gilead Sciences GILD Stock Holding History

Torrey Growth & Income Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,310
Closed -$256K – 125
2025
Q3 		$256K Buy
+2,310
New +$263K 0.08% 105

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Torrey Growth & Income Advisors's GILD Position: Q4 2025 in Review

Torrey Growth & Income Advisors sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 2,310 shares — an estimated $256K sold.

Torrey Growth & Income Advisors first reported a position in GILD in Q3 2025 and held it in 1 quarter. The position peaked at $256K in Q3 2025. 2,221 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Torrey Growth & Income Advisors reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Torrey Growth & Income Advisors sold 2,310 Gilead Sciences shares in Q4 2025, an estimated $256K.
  • Torrey Growth & Income Advisors first reported a position in Gilead Sciences in Q3 2025 and held it in 1 quarter.
  • Torrey Growth & Income Advisors's Gilead Sciences position peaked at $256K in Q3 2025.
  • 2,221 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Torrey Growth & Income Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.